{"product_id":"cjc-1295-no-dac","title":"CJC 1295 (no dac)10mg vial","description":"\u003cp\u003eCJC-1295 No DAC\u003c\/p\u003e\n\u003cp\u003eWhat is CJC-1295 No DAC?\u003c\/p\u003e\n\u003cp\u003eCJC-1295 No DAC, also known as Modified GRF (1-29) or Mod GRF (1-29), is a synthetic 29-amino-acid analogue of growth hormone-releasing hormone (GHRH). It has the molecular formula C₁₅₂H₂₅₂N₄₄O₄₂, a molecular weight of approximately 3367.9 g\/mol, and the CAS number 863288-34-0.\u003c\/p\u003e\n\u003cp\u003eUnlike CJC-1295 DAC, this variant does not contain the Drug Affinity Complex (DAC) modification, resulting in a shorter duration of biological activity. It is widely used as a research peptide for investigating growth hormone-releasing hormone receptor signalling and endocrine physiology.\u003c\/p\u003e\n\u003cp\u003eHybrid 2.0 supplies CJC-1295 No DAC exclusively as a lyophilised peptide for laboratory and scientific research.\u003c\/p\u003e\n\u003cp\u003eChemical Identifiers\u003c\/p\u003e\n\u003cp\u003eCAS Number: 863288-34-0\u003c\/p\u003e\n\u003cp\u003eMolecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂\u003c\/p\u003e\n\u003cp\u003eMolecular Weight: 3367.9 g\/mol\u003c\/p\u003e\n\u003cp\u003ePubChem CID: 56841945\u003c\/p\u003e\n\u003cp\u003eLegal Status in the UK\u003c\/p\u003e\n\u003cp\u003eCJC-1295 No DAC is not a controlled drug under the Misuse of Drugs Act 1971 and is not a scheduled substance.\u003c\/p\u003e\n\u003cp\u003eIt is not authorised by the MHRA as a licensed medicine and must not be supplied, marketed or used for human or veterinary consumption.\u003c\/p\u003e\n\u003cp\u003eHybrid 2.0 supplies this peptide strictly for laboratory and scientific research. Purchasers are responsible for complying with all applicable laws and regulations.\u003c\/p\u003e\n\u003cp\u003eMechanism of Action\u003c\/p\u003e\n\u003cp\u003eCJC-1295 No DAC functions as an analogue of growth hormone-releasing hormone (GHRH), binding to GHRH receptors located on somatotroph cells within the anterior pituitary gland.\u003c\/p\u003e\n\u003cp\u003eExperimental research has shown that activation of these receptors stimulates physiological growth hormone signalling pathways. Because this analogue lacks the Drug Affinity Complex (DAC) modification, it exhibits a shorter biological activity than the DAC-modified form, making it useful for comparative studies of GHRH receptor pharmacology and endocrine regulation.\u003c\/p\u003e\n\u003cp\u003eAreas of Research Interest\u003c\/p\u003e\n\u003cp\u003eCurrent scientific research is investigating CJC-1295 No DAC in relation to:\u003c\/p\u003e\n\u003cp\u003eGrowth hormone-releasing hormone receptor signalling\u003c\/p\u003e\n\u003cp\u003eGrowth hormone physiology\u003c\/p\u003e\n\u003cp\u003eEndocrine regulation\u003c\/p\u003e\n\u003cp\u003eIGF-1 signalling pathways\u003c\/p\u003e\n\u003cp\u003eNeuroendocrine physiology\u003c\/p\u003e\n\u003cp\u003ePeptide pharmacology\u003c\/p\u003e\n\u003cp\u003eComparative GHRH analogue research\u003c\/p\u003e\n\u003cp\u003eThese remain active areas of scientific investigation and should not be interpreted as established therapeutic uses.\u003c\/p\u003e\n\u003cp\u003eCurrent Research Applications\u003c\/p\u003e\n\u003cp\u003eCJC-1295 No DAC is commonly investigated in research relating to:\u003c\/p\u003e\n\u003cp\u003eEndocrinology\u003c\/p\u003e\n\u003cp\u003eGrowth hormone physiology\u003c\/p\u003e\n\u003cp\u003eReceptor pharmacology\u003c\/p\u003e\n\u003cp\u003ePeptide signalling\u003c\/p\u003e\n\u003cp\u003eNeuroendocrine research\u003c\/p\u003e\n\u003cp\u003eExperimental metabolic physiology\u003c\/p\u003e\n\u003cp\u003eComparative peptide research\u003c\/p\u003e\n\u003cp\u003eThese applications are intended solely for laboratory and scientific investigation and should not be interpreted as evidence of clinical efficacy.\u003c\/p\u003e\n\u003cp\u003eSummary\u003c\/p\u003e\n\u003cp\u003eCJC-1295 No DAC is a short-acting GHRH analogue that remains an important research tool for investigating endogenous growth hormone signalling and endocrine physiology. Ongoing studies continue to explore its receptor interactions, pharmacological characteristics and role within experimental models of hormone regulation.\u003c\/p\u003e\n\u003cp\u003eResearch Disclaimer\u003c\/p\u003e\n\u003cp\u003eFor Research Use Only. Not for human consumption or veterinary use. Products supplied by Hybrid 2.0 are intended strictly for laboratory and scientific research purposes. Any information provided is for educational and scientific discussion only and should not be interpreted as medical advice, therapeutic claims, or evidence of clinical efficacy.\u003c\/p\u003e","brand":"hybrid2.0","offers":[{"title":"Default Title","offer_id":58788304978245,"sku":null,"price":31.45,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1069\/2870\/1765\/files\/rn-image_picker_lib_temp_fb2f963e-6296-4cae-867e-5d24f43a0b61.png?v=1786033115","url":"https:\/\/hybrid2-0.co.uk\/products\/cjc-1295-no-dac","provider":"hybrid2.0","version":"1.0","type":"link"}